Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,192
Closed -$351K 200
2025
Q3
$351K Sell
5,192
-988
-16% -$71.6K 0.1% 157
2025
Q2
$461K Sell
6,180
-3,032
-33% -$202K 0.14% 116
2025
Q1
$580K Sell
9,212
-630
-6% -$39K 0.19% 86
2024
Q4
$561K Sell
9,842
-2,980
-23% -$176K 0.2% 84
2024
Q3
$754K Buy
12,822
+168
+1% +$9.17K 0.28% 78
2024
Q2
$683K Buy
12,654
+1,021
+9% +$56.2K 0.28% 68
2024
Q1
$671K Buy
11,633
+1,087
+10% +$56.1K 0.28% 70
2023
Q4
$505K Buy
+10,546
New +$503K 0.23% 85
2022
Q2
Sell
-6,450
Closed -$371K 119
2022
Q1
$371K Sell
6,450
-6,589
-51% -$337K 0.2% 81
2021
Q4
$616K Buy
+13,039
New +$594K 0.3% 56

Other funds holding CTVA

Rovin Capital's CTVA Position: Q4 2025 in Review

Rovin Capital sold out of Corteva (CTVA) in Q4 2025, closing a stake of 5,192 shares — an estimated $351K sold.

Rovin Capital first reported a position in CTVA in Q4 2021 and held it in 10 quarters. The position peaked at $754K in Q3 2024. 1,422 funds tracked by Wall St. Rank hold CTVA as of Q4 2025.

  • Rovin Capital reported no remaining Corteva position as of Q4 2025 after selling out during the quarter.
  • Rovin Capital sold 5,192 Corteva shares in Q4 2025, an estimated $351K.
  • Rovin Capital first reported a position in Corteva in Q4 2021 and held it in 10 quarters.
  • Rovin Capital's Corteva position peaked at $754K in Q3 2024.
  • 1,422 funds tracked by Wall St. Rank held Corteva as of Q4 2025.

Based on Rovin Capital's 13F filing for Q4 2025, filed 9 Feb 2026.